The CLL landscape continues to change very quickly. I have previously written about picking a first line therapy, but my post from 2013 has become quickly outdated.
I recently had the opportunity to participate with a group called "Clinical Care Options" on a decision support tool that allows you to plug in a variety of variables that are central to picking out a treatment regimen and then seeing what therapy would be selected by a handful of experts.
To use the tool, you have to register for an account - but I thought it would be worth it for a number of patients who are at the point of picking out a particular therapy.
Here is a link to the tool
I also serve on the CLL Steering Committee for Medscape. We have recently conducted several taped interviews discussing how to pick therapy in both the front line and relapsed / refractory setting. Here again, you need to sign up for an account - but worth it if you want more color commentary regarding the tool outlined above.
Here is the link for the frontline video with me and Steve Coutre
Here is the link for the the relapsed / refractory video with Stephen Schuster, Matthew Davids and Amy Goodrich
I would like to predict that these will remain relevant tools for the foreseeable future but I am happy to report that they will only be valuable for another 12-24 months before the world changes again.
I tried to embed these tools directly on the blog but unfortunately was not able to do so. I hope you find them helpful.
Thanks for reading / viewing / tooling.
